Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.
Hosted on MSN9h
Cancer: 'I'm a doctor - most experts look for the same key indicator that a lump could be serious'Despite being a common occurrence, the appearance of lumps and bumps on the body can be quick to stir concern. For many ...
When caught early, skin cancer is highly treatable. Find out if there is a free skin cancer check near you by using the map below. Clicking on your state will show you the scheduled free skin cancer ...
T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback